Navigation Links
Micromet Closes $80.5 Million Public Offering of Common Stock
Date:3/17/2010

el antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials.  Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including sanofi-aventis, Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed.

Safe Harbor Statement

This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Any statements contained herein which do not describe historical facts, including but not limited to, statements regarding the intended use of the net proceeds of the offering, are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Such risks and uncertainties include uncertainties and other risks identified in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2009. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. We disclaim any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual resul
'/>"/>

SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Announces Proposed Public Offering of Common Stock
2. Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day
3. Final Data from Phase 2 Study Confirm High Response Rate of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
4. Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
5. Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
6. Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
7. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
8. Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
9. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
10. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
11. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... LONDON , March 27, 2015 ... commercial prospects for leading ophthalmic drug companies  ... the pharma ophthalmic industry ? Visiongain,s brand new ... trends, opportunities and prospects there. Our 242-page ... most lucrative areas in the industry and the future ...
(Date:3/27/2015)... 27, 2015   Hospira, Inc. (NYSE: ... and the world,s leading provider of injectable drugs ... an evaluation of biosimilarity of its proposed biosimilar, ... Administration (FDA) conditionally approved name of RETACRIT™, compared ... These study data were presented at the National ...
(Date:3/27/2015)... BEIJING , March 27, 2015 ... the "Company") (NYSE: CCM ), a leading ... the largest network of radiotherapy and diagnostic imaging ... announced the signing of a purchase agreement under ... wholly owned subsidiary of the Company, agreed to ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3
... announces that a new market research report is ... Drug Discovery in Emerging Markets ... markets have represented important growth opportunities for the ... the extent to which this has been accompanied ...
... Calif., Jan. 11, 2011 STAAR Surgical Company (Nasdaq: ... marketer of minimally invasive ophthalmic products, today announced that ... 31, 2010 to exceed $14.2 million. Revenues for the ... over 2009 revenues, driven by an increase of approximately ...
Cached Medicine Technology:Reportlinker Adds Innovative Drug Discovery in Emerging Markets 2Reportlinker Adds Innovative Drug Discovery in Emerging Markets 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Designers and ... new overlay entitled Scratches 5K from Pixel Film Studios. ... effects to any media inside Final Cut Pro X” ... Corporate saves time and is an effective tool for ... FCPX Overlay Scratches 5K's intuitive grunge overlays. Simply drag ...
(Date:3/28/2015)... 28, 2015 Servpro of Paso ... week released a report about the link between mold ... sufferers, and according to recent medical research, may even ... to the Environmental Protection Agency, people with sensitivity to ... in mold may trigger asthma attacks for asthma sufferers. ...
(Date:3/27/2015)... 2015 Wellness for Cancer–the first organization ... for the spa and wellness industry–has certified Hands On ... experienced or are living with cancer. Hands On ... Network, will be identified with a special Wellness for ... of safe, therapeutic services for cancer patients. , Wellness ...
(Date:3/27/2015)... New York (PRWEB) March 27, 2015 ... http://www.lipitorlawsuitcenter.com/ ) that allege the statin medication increases the ... has granted Pfizer Inc.’s Motion to Dismiss four individual ... to a Case Management Order issued in the U.S. ... the Court determined that the dismissals were warranted because ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 2Health News:Lipitor Lawsuits Move Forward in Federal Multidistrict Litigation, as Court Rules on Pfizer’s Motion to Dismiss Certain Cases 3
... 7, 2008 CardWorks Servicing, LLC,("CardWorks") the largest ... Cardholder Management Services, LLC ("CMS"), announced,today that the ... HumanaAdvance,Visa Card. CardWorks will partner with E-Duction, Inc., ... HumanaAdvance Visa. Humana,is one of the nation,s largest ...
... shows proteins from the reptiles can fight off ,superbugs, , , ... of gator aid. New research suggests that alligator blood could ... by ulcers, burns and even drug-resistant "superbugs." , The research ... have only been tested in the laboratory -- and there,s ...
... - Roundtable to examine the crisis in science education, scientific research, ... ... Election -, NEW YORK, April 7, 2008 ... explored some of the most complex,science and human health issues facing the ...
... Edmond Medical Center and,ophthalmologists M. Andrew Hogue, M.D. and ... once again participate in the Mission,Cataract Campaign, a program ... afford to pay., Appointments can be made for ... qualifies for the cataract surgery and is in,financial need ...
... 2008 Principals announced today a $3,billion dollar ... with,chemical manufacturer W.R.Grace & Co. and related entities, ... from bankruptcy,with no further obligations for asbestos injury ... the 1970,s., Terms of the agreement will ...
... 7, 2008 Schoolchildren,who required surgery as infants ... of having problems with inattention and hyperactivity, and,often ... at risk for,academic and behavior problems, and our ... with ongoing follow-up and neurodevelopmental,screening," said study leader ...
Cached Medicine News:Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 2Health News:CardWorks Named Servicer of Choice for Innovative Credit Card for Healthcare Services 3Health News:Gator Blood May Be New Source of Antibiotics 2Health News:Gator Blood May Be New Source of Antibiotics 3Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 2Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 3Health News:Edmond Medical Center to Provide Free Cataract Surgeries 2Health News:$3 Billion Asbestos Deal Reached by W.R.Grace Company to Pay Asbestos Victims 2Health News:For Children With Heart Disease, a Risk of Attention and Behavior Problems 2
... a malleable, single-use cryosurgical probe developed to ... probe will ablate cardiac tissue while a ... procedure, such as coronary artery bypass grafting ... repair and as part of the Maze ...
Steerable catheter that is ideal for mapping unusual anatomy...
... Mapping. The LASSO Circular Mapping Catheter from ... capable of circumferentially mapping the myocardial sleeves ... design allows the sequential assessment of PV ... vein isolation. The circular LASSO curve ...
Standard Deflectable Catheters...
Medicine Products: